| Literature DB >> 35322051 |
Shivani Kumar1, Chitteti Ramamurthy1, Divya Choudhary2, Aashika Sekar3, Anupam Patra4, Neel Sarovar Bhavesh4, Perumal Vivekanandan5.
Abstract
Herpesviruses are known to acquire several genes from their hosts during evolution. We found that a significant proportion of virus homologues encoded by HSV-1, HSV-2, EBV and KSHV and their human counterparts contain G-quadruplex motifs in their promoters. We sought to understand the role of G-quadruplexes in the regulatory regions of viral Bcl-2 homologues encoded by KSHV (KS-Bcl-2) and EBV (BHRF1). We demonstrate that the KSHV KS-Bcl-2 and the EBV BHRF1 promoter G-quadruplex motifs (KSHV-GQ and EBV-GQ) form stable intramolecular G-quadruplexes. Ligand-mediated stabilization of KS-Bcl-2 and BHRF1 promoter G-quadruplexes significantly increased the promoter activity resulting in enhanced transcription of these viral Bcl-2 homologues. Mutations disrupting KSHV-GQ and EBV-GQ inhibit promoter activity and render the KS-Bcl-2 and the BHRF1 promoters non-responsive to G-quadruplex ligand. In contrast, promoter G-quadruplexes of human bcl-2 gene inhibit promoter activity. Further, KS-Bcl-2 and BHRF1 promoter G-quadruplexes augment RTA (a virus-encoded transcription factor)-mediated increase in viral bcl-2 promoter activity. In sum, this work highlights how human herpesviruses have evolved to exploit promoter G-quadruplexes to regulate virus homologues to counter their cellular counterparts.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35322051 PMCID: PMC8943185 DOI: 10.1038/s41598-022-08161-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 3Biophysical analyses of KSHV-GQ and EBV-GQ reveals formation of stable intramolecular G-quadruplex in vitro. (a) CD spectra of Wt-KSHV-GQ and Wt-EBV-GQ show formation of hybrid (mixed type) and parallel G-quadruplex structures, respectively. Mutations were introduced to disrupt the G-quadruplex (Mut-KSHV-GQ and Mut-EBV-GQ). As expected, the mutant oligonucleotides did not form G-quadruplexes. (b) Native and denaturing polyacrylamide gel electrophoresis experiments reveal formation of intramolecular secondary structures attributed to the higher mobility of wild type oligonucleotides i.e., Wt-KSHV-GQ and Wt-EBV-GQ when compared with that of mutants (Mut-KSHV-GQ and Mut-EBV-GQ) and length match controls that do not form DNA secondary structures. (c) 1D 1H NMR spectra of Wt-KSHV-GQ and Wt-EBV-GQ oligonucleotide show resonance peaks of imino protons between 10.5–12 ppm, confirming the formation of G-quadruplexes. The NMR spectra suggest that Mut-KSHV-GQ and Mut-EBV-GQ do not form G-quadruplexes. (d) DMS footprinting experiments using 5’ FAM labelled oligonucleotides Wt-KSHV-GQ and Wt-EBV-GQ show formation of intramolecular G-quadruplex structures. Footprinting experiments were performed using different KCl concentrations {500 mM, 100 mM, and 0 mM (i.e., no KCl)}. AG represents seq uencing cleavage reactions specific to purine residues. The vertical bars next to the sequence of the oligonucleotide represents the G residues protected from DMS methylation due to formation of G-quadruplex structure. It is to be noted that the ladder (AG cleavage reaction lane) of the footprinting gel of Wt-KSHV-GQ has been snipped off from another part of the same gel and aligned together with the quadruplex sequence cleavage reaction lanes for comparison.
Figure 7G-quadruplex-mediated regulation of viral and human Bcl-2 expression and its potential effect on host cell apoptosis. The G-quadruplexes in human Bcl-2 promoters inhibit gene expression; this may promote apoptosis of the host cell. The G-quadruplexes in viral Bcl-2 (vBcl-2) promoters serve to enhance vBcl-2 expression. Further, the G-q uadruplexes in vBcl-2 promoters contribute to RTA mediated enhancement of promoter activity. Thus, G-quadruplexes in vBcl-2 promoters enhance vBcl-2 expression which can potentially inhibit host cell apoptosis and thereby confer survival advantage to the virus.
Figure 1A significant proportion of promoters of human genes captured by herpesviruses and the corresponding virus homologues contain at least one PQS motif. (a) Pie charts show the proportion of promoters of human genes (~ 79%) captured by herpesviruses and that of corresponding herpesvirus homologues (~ 42%) with at least 1 PQS motif. (b) Bar graph shows the percentage of viral homologues from human herpesviruses with at least 1 PQS motif in their upstream regulatory regions. Promoters of virus homologues from HHV1, HHV2 and gammaherpes viruses (HHV4 and HHV8) were enriched for PQS motifs. N denotes number of virus homologues.
PQS motifs in promoters of h uman herpesvirus homologues belonging to different functional classes.
| Gene class function | Human genes | Human herpesvirus genes | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Alpha | Beta | Gamma | |||||||
| 1 | 2 | 3 | 5 | 6A | 7 | 4 | 8 | ||
| DNA replication | DNA polymerase alpha (POLA) | ORF28 | UL54 | U38 | U38 | BALFS | ORF9 | ||
| DNA helicase (HFMl ) | ORF55 | UL1O5 | U77 | U77 | BBLF4 | ORF40 | |||
| Nucleotide repair & metabolism | Uracil DNA glycosylase (UNG1) | ORF59 | UL114 | U81 | U81 | ORF46 | |||
| Ribonucleotide reductase M1 (RRM1) | ORF19 | UL45 | U28 | U28 | ORF61 | ||||
| Ribonucleotide reductase M2 polypeptide (RRM2) | ORF18 | ORF60 | |||||||
| Thymidylate synthase (TYMS) | ORF13 | ORF70 | |||||||
| Dihydrofolate reductase (DHFR) | ORF2 | ||||||||
| Enzyme | Protein kinase cdc2-related PICTAIRE-2 (PCTK2) | UL3 | ORF58 | UL83 | U54 | U54 | ORF36 | ||
| Serine/threonine-protein kinase PRP4 (PRP4) | ORF66 | ||||||||
| Gene expression regulation | Ring finger protein (C3H2C3 type) 6 (RFP) | ||||||||
| Glycoprotein | OX-2 membrane glycoprotein precursor (OX-2) | U85 | U85 | K14 | |||||
| Host-virus interaction | Flap structure-specific endonuclease 1 (FEN1) | ORF17 | |||||||
| chemokine (C–C motif) receptor 2 (CKR2) | US1 | US1 | |||||||
| G protein-coupled receptor 50 (GPR50) | U12 | U12 | ORF74 | ||||||
| Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) | UL144 | ||||||||
| Small inducible cytokine subf.B, member 9B (IP-9) | UL47 | ||||||||
| Small inducible cytokine subf.A, member 26 (TSC-1) | K4.1 | ||||||||
| Major histocompatibility complex, Class I,E (HLA1-E) | UL18 | ||||||||
| lnterleukin 10 (IL10) | |||||||||
| B-cell lymphoma protein 2 (Bcl-2) | |||||||||
| CD80 anti gen (CD80) | |||||||||
| Interferon consensus seq.binding protein 1 (ICSBP1) | |||||||||
| Interferon regulatory protein 4 (IRF4) | |||||||||
| lnterleukin 6 (IL6) | |||||||||
| Decay accelerating factor for complement (DAF) | |||||||||
| Cyclin D1 (CCND1) | |||||||||
| Major histocompatibility complex, Class I (HLA1) | |||||||||
| CASPS and FADD-Iike apoptosis regulator (FLIP) | ORF71 | ||||||||
All human herpesvirus gene homologues of human genes were broadly classified into 6 functional groups based on gene function. The viral genes with ≥ 1 PQS motif in their 1 kb upstream regulatory region (promoter region) are represented in bold font.
Figure 2PQS motifs in regulatory regions of viral Bcl-2 homologues encoded by KSHV and EBV. (a) Bar graph shows PQS density in the 1 kb upstream regulatory region of KSHV KS-Bcl-2 and EBV BHRF1 genes. The PQS densities in the native sequences were significantly higher than that in the randomized sequences (shuffled sequences with constant dinucleotide content; detailed in "Materials and methods" section) (p < 0.001). (b) Schematic representation of the G-quadruplex motif closest to the TSS in KS-Bcl-2 and BHRF1 promoters. We refer to this G-quadruplex motif in KS-Bcl-2 and EBV BHRF1 as KSHV-GQ and EBV-GQ. Analysis of all full-length genomes from KSHV and EBV suggest that the KSHV-GQ and the EBV GQ are hi ghly conserved. *KS-Bcl-2 gene promoter (1 kb) was found to contain 3 PQS motifs at -207 nt., -255 nt., and -288 nt. from the TSS. Only the PQS motif closest to the TSS (at − 207 nt.) is represented in the schematic.
Figure 4CD and UV melting studies reveal PDS-mediated stabilization of KSHV-GQ and EBV-GQ oligonucleotides. Melting analyses (20–93 °C) was performed on Wt-KSHV-GQ and Wt-EBV-GQ oligonucleotides with and without PDS (G-qu adruplex binding ligand) (a–d). As observed, PDS stabilized both KSHV-GQ and EBV-GQ. ΔTm is defined as the difference between the Tm (melting temperature) of the PQS oligonucleotide in the presence and absence of ligand.
Figure 5Contrasting roles for promoter G-quadruplexes in human Bcl-2 and viral Bcl-2 expression. Bar graphs show promoter activity as estimated by measuring firefly luciferase levels normalized with renilla luciferase levels (transfection control). The relative luciferase units (RLU) values of the mutant constructs (Mut-KSHV-GQ and Mut-EBV-GQ) were normalized to that of the respective wild-type constructs (Wt-KSHV-GQ and Wt-EBV-GQ). (a) Previous studies have established that G-quadruplexes are found in abundance in human bcl-2 gene promoter and hence regulate its expression. Our luciferase reporter assay data is in conformity with this previously known fact. We observed that the human Bcl-2 promoter activity was significantly reduced upon exposure to PDS (5 µM). (b) The Wt-KSHV-GQ construct (with an intact G-quadruplex) has significantly higher promoter activity compared to that of the Mut-KSHV-GQ construct (possesses mutations disrupting G-quadruplex in the KS-Bcl-2 promoter). The addition of PDS (5 μM) led to a significant increase in promoter activity of the Wt-KSHV-GQ promoter. (c) The Wt-EBV-GQ construct (wild-type EBV BHRF1 promoter with an intact G-quadruplex) also exhibit higher promoter activity compared to that of the Mut-EBV-GQ construct (possesses mutations disrupting G-quadruplex in the BHRF1 promoter). We also observed that addition of PDS (5 μM) increased the promoter activity of Wt-EBV-GQ construct significantly. It is also clear from (b,c) that exposure to PDS does not alter the promoter activity the mutant reporter constructs i.e., Mut-KSHV-GQ and Mut-EBV-GQ; both containing G-quadruplex disrupting mutations). Data are depicted as mean ± SD with n = 4 replicates. (d) Our findings are summarized in a pictorial representation highlighting that G-quadruplexes present upstream of viral Bcl-2 homologues (i.e., KS-Bcl-2 and BHRF1) exert a positive regulatory effect on promoter activity. This finding is in contrast to the negative regulatory role for the promoter G-quadruplexes in human Bcl-2 that has been previously reported and reconfirmed under the same conditions we tested the viral Bcl-2 promoters.
Figure 6KSHV-GQ and EBV-GQ contribute to RTA induced expression of viral Bcl-2. Promoter activity of (a) KSHV KS-Bcl-2 and (b) EBV BHRF1 promoters were greatly enhanced upon co-transfection of KSHV RTA and EBV RTA, respectively. While the promoter activity of mutant promoters (with disrupted GQs) also increased significantly in the presence of viral RTAs, the extent (or fold-change) of RTA-mediated enhancement of promoter activity in the wild-type promoters (i.e., KSHV KS-Bcl-2 and EBV BHRF1) were more pronounced. Experiments were performed in triplicates and mean values ± SD are plotted.